{"id":"lypressin","rwe":[],"tags":[{"label":"lypressin","category":"class"},{"label":"Peptide","category":"modality"},{"label":"Vasopressin receptor","category":"target"},{"label":"AVPR1A","category":"gene"},{"label":"AVPR1B","category":"gene"},{"label":"AVPR2","category":"gene"},{"label":"H01BA03","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Partial Central Diabetes Insipidus","category":"indication"},{"label":"Novartis","category":"company"},{"label":"Antidiuretic Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Coagulants","category":"pharmacology"},{"label":"Hematologic Agents","category":"pharmacology"},{"label":"Hemostatics","category":"pharmacology"},{"label":"Natriuretic Agents","category":"pharmacology"},{"label":"Vasoconstrictor Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Novartis","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=LYPRESSIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:08:47.993428+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:09:01.719335+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:08:53.062403+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LYPRESSIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:08:53.728719+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Vasopressin receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:08:54.799269+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200690/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:08:54.453380+00:00"}},"allNames":"lysipressin","offLabel":[],"synonyms":["lypressin","lysine pitressin","lysine vasopressin","lysipressin","lysopressin","lysylvasopressin","syntopressin"],"timeline":[],"aiSummary":"LYPRESSIN, marketed by Novartis, is a lysipressin-based treatment for partial central diabetes insipidus, competing in a niche but critical therapeutic area. Its key strength lies in its mechanism of action, which effectively mimics the antidiuretic hormone to regulate fluid balance, offering a targeted solution for patients. The primary risk is the upcoming patent expiry in 2028, which could lead to increased competition from generic alternatives.","approvals":[{"date":"","orphan":false,"company":"NOVARTIS","regulator":"FDA"}],"brandName":"Lysipressin","ecosystem":[{"indication":"Partial Central Diabetes Insipidus","otherDrugs":[{"name":"desmopressin","slug":"desmopressin","company":"Ferring Pharms Inc"},{"name":"lysine","slug":"lysine","company":""},{"name":"vasopressin","slug":"vasopressin","company":"Parke Davis"}],"globalPrevalence":null}],"mechanism":{"target":"Vasopressin receptor","novelty":"First-in-class","targets":[{"gene":"AVPR1A","source":"DrugCentral","target":"Vasopressin receptor","protein":"Vasopressin V1a receptor"},{"gene":"AVPR1B","source":"DrugCentral","target":"Vasopressin receptor","protein":"Vasopressin V1b receptor"},{"gene":"AVPR2","source":"DrugCentral","target":"Vasopressin receptor","protein":"Vasopressin V2 receptor"}],"modality":"Peptide","drugClass":"lypressin","explanation":"","oneSentence":"","technicalDetail":"Lypressin is a synthetic analogue of vasopressin that selectively binds to V2 receptors in the kidneys, promoting water reabsorption and reducing urine production."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2959","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=LYPRESSIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LYPRESSIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:05:14.465156","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:09:01.719430+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"vasopressin","drugSlug":"vasopressin","fdaApproval":"","patentExpiry":"Sep 27, 2044","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"desmopressin","drugSlug":"desmopressin","fdaApproval":"1978-02-21","patentExpiry":"May 21, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"terlipressin","drugSlug":"terlipressin","fdaApproval":"2022-09-14","patentExpiry":"Apr 5, 2037","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"lypressin","indications":{"approved":[{"name":"Partial Central Diabetes Insipidus","source":"DrugCentral","snomedId":"","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"vasopressin","brandName":"vasopressin","genericName":"vasopressin","approvalYear":"","relationship":"same-class"},{"drugId":"desmopressin","brandName":"desmopressin","genericName":"desmopressin","approvalYear":"1978","relationship":"same-class"},{"drugId":"terlipressin","brandName":"terlipressin","genericName":"terlipressin","approvalYear":"2022","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07460908","phase":"NA","title":"Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome","status":"COMPLETED","sponsor":"Lahore General Hospital","startDate":"2025-05-01","conditions":["Hepatorenal Syndrome"],"enrollment":60,"completionDate":"2025-10-30"},{"nctId":"NCT07304466","phase":"NA","title":"Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Istanbul Medipol University Hospital","startDate":"2025-12-29","conditions":["Liver Transplantation","Portal Hypertension"],"enrollment":50,"completionDate":"2027-03-30"},{"nctId":"NCT06161766","phase":"","title":"Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease","status":"COMPLETED","sponsor":"University Hospital Freiburg","startDate":"2024-03-03","conditions":["Liver Cirrhosis","Hepato-Renal Syndrome","Chronic Kidney Diseases"],"enrollment":490,"completionDate":"2024-12-31"},{"nctId":"NCT07252401","phase":"NA","title":"Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Gastrointestinal Bleeding and Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-12-25","conditions":["Liver Cirrhosis"],"enrollment":64,"completionDate":"2028-03-31"},{"nctId":"NCT06855758","phase":"NA","title":"Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2025-03-06","conditions":["Kidney Transplant","Delayed Graft Function","Intraoperative Hypotension"],"enrollment":150,"completionDate":"2027-06"},{"nctId":"NCT06256432","phase":"PHASE2","title":"Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome","status":"RECRUITING","sponsor":"Noorik Biopharmaceuticals AG","startDate":"2024-04-17","conditions":["Hepatorenal Syndrome","Liver Cirrhosis","Acute Kidney Injury","Ascites Hepatic"],"enrollment":54,"completionDate":"2026-02"},{"nctId":"NCT05346393","phase":"NA","title":"HRS-AKI Treatment With TIPS in Patients With Cirrhosis","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2022-11-29","conditions":["Cirrhosis, Liver","Hepatorenal Syndrome","Acute Kidney Injury","Ascites Hepatic"],"enrollment":124,"completionDate":"2026-06"},{"nctId":"NCT04460560","phase":"PHASE3","title":"Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-12-11","conditions":["Hepatorenal Syndrome"],"enrollment":50,"completionDate":"2023-12-27"},{"nctId":"NCT06556472","phase":"NA","title":"Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-08-15","conditions":["Acute on Chronic Liver Failure"],"enrollment":126,"completionDate":"2025-08-31"},{"nctId":"NCT05170230","phase":"NA","title":"The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations","status":"RECRUITING","sponsor":"Wael Elbanna Clinic","startDate":"2022-02-27","conditions":["Myoma"],"enrollment":99,"completionDate":"2026-06-30"},{"nctId":"NCT05242783","phase":"NA","title":"The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:","status":"COMPLETED","sponsor":"Wael Elbanna Clinic","startDate":"2022-02-01","conditions":["Myoma"],"enrollment":99,"completionDate":"2024-06-20"},{"nctId":"NCT05154279","phase":"NA","title":"The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations","status":"RECRUITING","sponsor":"Wael Elbanna Clinic","startDate":"2022-02-27","conditions":["Laparoscopic Myomectomy"],"enrollment":99,"completionDate":"2026-03-30"},{"nctId":"NCT04961528","phase":"PHASE3","title":"ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-27","conditions":["Hemoptysis"],"enrollment":315,"completionDate":"2026-01-31"},{"nctId":"NCT03130127","phase":"NA","title":"Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis","status":"UNKNOWN","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-07-01","conditions":["Liver Cirrhosis","Portal Hypertension","Variceal Hemorrhage","Bleeding","Esophageal and Gastric Varices"],"enrollment":40,"completionDate":"2025-12-01"},{"nctId":"NCT05774067","phase":"NA","title":"Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-01","conditions":["Norepinephrine, Glypressin, Tourniquet Deflation","Hypotension"],"enrollment":135,"completionDate":"2023-07-30"},{"nctId":"NCT06108362","phase":"PHASE4","title":"Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients","status":"UNKNOWN","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2023-08-18","conditions":["Acute Kidney Injury","Liver Transplant; Complications"],"enrollment":104,"completionDate":"2024-06-30"},{"nctId":"NCT05875948","phase":"PHASE2","title":"Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome","status":"UNKNOWN","sponsor":"River 2 Renal Corp.","startDate":"2023-06-30","conditions":["Hepatorenal Syndrome","Acute Kidney Injury"],"enrollment":95,"completionDate":"2024-12"},{"nctId":"NCT06027970","phase":"PHASE3","title":"Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2023-09","conditions":["Variceal Hemorrhage"],"enrollment":165,"completionDate":"2024-12"},{"nctId":"NCT03572088","phase":"PHASE2","title":"Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion Needs","status":"COMPLETED","sponsor":"Assiut University","startDate":"2016-05","conditions":["Terlipressin","Blood Loss"],"enrollment":40,"completionDate":"2017-07"},{"nctId":"NCT03822091","phase":"PHASE3","title":"Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-01-28","conditions":["Type 1 HEPATO RENAL SYNDROME(HRS)"],"enrollment":60,"completionDate":"2020-01-30"},{"nctId":"NCT05207280","phase":"PHASE3","title":"Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic Shock","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-10-11","conditions":["Septic Shock"],"enrollment":152,"completionDate":"2024-11"},{"nctId":"NCT05806307","phase":"PHASE4","title":"Methods Decreasing Bleeding in Open Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03-15","conditions":["Misoprostol Allergy","Oxytocin Allergy","Tranexamic Acid Allergy","Ethamsylate Allergy","Myoma","Blood Loss, Surgical"],"enrollment":105,"completionDate":"2023-11-30"},{"nctId":"NCT04416282","phase":"NA","title":"Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-06-22","conditions":["Acute-On-Chronic Liver Failure","Hepatorenal Syndrome","Acute Kidney Injury"],"enrollment":70,"completionDate":"2022-06-10"},{"nctId":"NCT02770716","phase":"PHASE3","title":"Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2016-07-13","conditions":["Hepatorenal Syndrome"],"enrollment":300,"completionDate":"2019-07-24"},{"nctId":"NCT01143246","phase":"PHASE3","title":"A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2010-10-11","conditions":["Hepatorenal Syndrome"],"enrollment":196,"completionDate":"2013-05-10"},{"nctId":"NCT05315557","phase":"NA","title":"Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-04-05","conditions":["Septic Shock","Cirrhosis, Liver"],"enrollment":100,"completionDate":"2023-03-31"},{"nctId":"NCT05266534","phase":"NA","title":"The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets","status":"RECRUITING","sponsor":"Wael Elbanna Clinic","startDate":"2021-12-30","conditions":["Myoma"],"enrollment":162,"completionDate":"2026-12-30"},{"nctId":"NCT04819568","phase":"NA","title":"Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-06-25","conditions":["Liver Cirrhosis"],"enrollment":310,"completionDate":"2022-03-19"},{"nctId":"NCT05080543","phase":"PHASE1","title":"Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients","status":"UNKNOWN","sponsor":"Amany Mousa Salama Muhammed","startDate":"2021-10","conditions":["Septic Shock"],"enrollment":36,"completionDate":"2022-10"},{"nctId":"NCT04339868","phase":"PHASE2","title":"Terlipressin for Refractory Septic Shock","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2020-04-03","conditions":["Septic Shock","Refractory Shock","Norepinephrine Adverse Reaction"],"enrollment":130,"completionDate":"2025-07-31"},{"nctId":"NCT04028323","phase":"PHASE4","title":"Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2019-07-16","conditions":["Renal Function Disorder","Acute Variceal Bleeding"],"enrollment":60,"completionDate":"2022-10-15"},{"nctId":"NCT03107091","phase":"PHASE2","title":"Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites","status":"COMPLETED","sponsor":"BioVie Inc.","startDate":"2017-07-15","conditions":["Cirrhosis","Ascites Hepatic"],"enrollment":6,"completionDate":"2019-04-25"},{"nctId":"NCT04358016","phase":"PHASE4","title":"Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2018-01-01","conditions":["Cirrhosis, Liver","Upper Gastrointestinal Bleeding"],"enrollment":54,"completionDate":"2020-03-01"},{"nctId":"NCT04353193","phase":"PHASE4","title":"Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.","status":"UNKNOWN","sponsor":"Juan A. Arnaiz","startDate":"2020-06","conditions":["Liver Cirrhosis Portal"],"enrollment":36,"completionDate":"2022-05"},{"nctId":"NCT04236115","phase":"PHASE4","title":"Comparison of Articaine and Prilocaine for Extraction of Maxillary Teeth","status":"COMPLETED","sponsor":"Taibah University","startDate":"2017-09-20","conditions":["Overcoming the Failure of Anaesthesia","Maxillary Teeth","Dental Extraction"],"enrollment":95,"completionDate":"2018-06-20"},{"nctId":"NCT04221672","phase":"PHASE3","title":"The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2019-11-07","conditions":["Terlipressin Adverse Reaction","Ascites Hepatic","Liver Failure","Acute Kidney Injury"],"enrollment":86,"completionDate":"2020-12-30"},{"nctId":"NCT03584087","phase":"PHASE4","title":"Efficacy of Terlipressin Therapy in Acute Variceal Haemorrhage After EVL","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2018-05-07","conditions":["Acute Variceal Haemorrhage"],"enrollment":74,"completionDate":"2019-07-31"},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":["Neonatal Sepsis","Refractory Shock"],"enrollment":36,"completionDate":"2020-02-19"},{"nctId":"NCT02695862","phase":"NA","title":"To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-05-05","conditions":["Acute Variceal Bleeding"],"enrollment":110,"completionDate":"2018-01-31"},{"nctId":"NCT04056806","phase":"PHASE4","title":"2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage","status":"UNKNOWN","sponsor":"E-DA Hospital","startDate":"2019-08","conditions":["Variceal Rebleeding Rate and Infections"],"enrollment":100,"completionDate":"2022-08"},{"nctId":"NCT03846180","phase":"","title":"Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2019-03-01","conditions":["Variceal Hemorrhage","Cirrhosis, Liver","Kidney Injury"],"enrollment":1682,"completionDate":"2019-07-01"},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":["Hypotension"],"enrollment":22435,"completionDate":"2018-12-29"},{"nctId":"NCT03395574","phase":"PHASE2","title":"Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2018-01-25","conditions":["Terlipressin Adverse Reaction","Liver Transplantation"],"enrollment":30,"completionDate":"2018-11-25"},{"nctId":"NCT03336814","phase":"PHASE4","title":"Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-07-27","conditions":["Septic Shock"],"enrollment":40,"completionDate":"2019-06-01"},{"nctId":"NCT03144713","phase":"NA","title":"Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2017-05-28","conditions":["Cirrhosis"],"enrollment":150,"completionDate":"2018-04-30"},{"nctId":"NCT03038503","phase":"PHASE3","title":"What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or Terlipressin","status":"UNKNOWN","sponsor":"Ramathibodi Hospital","startDate":"2016-12","conditions":["Septic Shock","Refractory Shock"],"enrollment":60,"completionDate":"2018-12"},{"nctId":"NCT01921985","phase":"PHASE2","title":"Terlipressin Administration in Patients Undergoing Major Liver Resection","status":"TERMINATED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2013-11","conditions":["Liver Resection","Liver Failure"],"enrollment":150,"completionDate":"2018-03"},{"nctId":"NCT03477461","phase":"","title":"Effects of Terlipressin on Management of Potential Organ Donors","status":"COMPLETED","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-01-01","conditions":["Organ Donors"],"enrollment":18,"completionDate":"2018-03-12"},{"nctId":"NCT00966355","phase":"PHASE4","title":"Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding","status":"COMPLETED","sponsor":"Korea University","startDate":"2006-09","conditions":["Variceal Bleeding, Cirrhosis"],"enrollment":1034,"completionDate":"2010-05"},{"nctId":"NCT02788240","phase":"NA","title":"To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase","status":"TERMINATED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-05-01","conditions":["Acute on Chronic Liver Failure"],"enrollment":14,"completionDate":"2017-07-15"},{"nctId":"NCT02588716","phase":"PHASE2","title":"Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-09","conditions":["Hepatectomy, Surgical Blood Loss, Terlipressin"],"enrollment":84,"completionDate":"2016-12"},{"nctId":"NCT02718599","phase":"PHASE2","title":"Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery","status":"COMPLETED","sponsor":"Assiut University","startDate":"2016-04","conditions":["Hemodynamics, Liver, Terlipressin"],"enrollment":50,"completionDate":"2017-07"},{"nctId":"NCT03352349","phase":"PHASE2","title":"Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2017-12-01","conditions":["Portal Vein Pressure"],"enrollment":30,"completionDate":"2018-12-30"},{"nctId":"NCT02573727","phase":"NA","title":"To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-10","conditions":["Acute on Chronic Liver Failure"],"enrollment":120,"completionDate":"2017-01"},{"nctId":"NCT02468063","phase":"NA","title":"To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-05-01","conditions":["Cirrhosis With Septic Shock"],"enrollment":184,"completionDate":"2017-05-31"},{"nctId":"NCT00089570","phase":"PHASE3","title":"Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2004-06","conditions":["Hepatorenal Syndrome"],"enrollment":112,"completionDate":"2006-09"},{"nctId":"NCT02368249","phase":"PHASE2","title":"Does Terlipressin Improve Renal Outcome After Liver Surgery","status":"WITHDRAWN","sponsor":"University of Zurich","startDate":"2020-01","conditions":["Kidney Failure"],"enrollment":0,"completionDate":"2025-02"},{"nctId":"NCT02059460","phase":"PHASE4","title":"Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney","status":"COMPLETED","sponsor":"National Liver Institute, Egypt","startDate":"2013-05","conditions":["Acute Kidney Injury","Liver Transplantation","Terlipressin","NGAL"],"enrollment":25,"completionDate":"2016-12"},{"nctId":"NCT01836224","phase":"NA","title":"Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-10","conditions":["Cirrhosis With Septic Shock"],"enrollment":84,"completionDate":"2014-09"},{"nctId":"NCT01649037","phase":"NA","title":"To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome","status":"WITHDRAWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-08","conditions":["Hepatorenal Syndrome"],"enrollment":0,"completionDate":"2015-06"},{"nctId":"NCT01530711","phase":"PHASE4","title":"Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response","status":"UNKNOWN","sponsor":"Pere Gines","startDate":"2012-04","conditions":["Cirrhosis","Hepatorenal Syndrome Type I"],"enrollment":40,"completionDate":"2016-12"},{"nctId":"NCT02119884","phase":"PHASE4","title":"Hemodynamic Effects of Terlipressin and High Dose Octreotide","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2014-02","conditions":["Gastric and Esophageal Varices"],"enrollment":88,"completionDate":"2016-06"},{"nctId":"NCT02757703","phase":"PHASE4","title":"Vasoactive Drugs in Real World Practice","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2010-05","conditions":["Vasoconstrictor Choice on Acute Variceal Bleeding"],"enrollment":150,"completionDate":"2015-01"},{"nctId":"NCT01640964","phase":"PHASE2","title":"An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-04","conditions":["Compensated Cirrhosis and Portal Hypertension"],"enrollment":47,"completionDate":"2014-12"},{"nctId":"NCT00628160","phase":"PHASE2,PHASE3","title":"Terlipressin in Septic Shock in Cirrhosis","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2006-10","conditions":["Liver Cirrhosis","Septic Shock"],"enrollment":72,"completionDate":"2012-12"},{"nctId":"NCT02489864","phase":"PHASE4","title":"The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-07","conditions":["Hepatorenal Syndrome"],"enrollment":30,"completionDate":"2017-12"},{"nctId":"NCT00986817","phase":"PHASE3","title":"Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-11","conditions":["Cirrhosis"],"enrollment":82,"completionDate":"2015-04"},{"nctId":"NCT01697410","phase":"NA","title":"Continuos Terlipressin Infusion in Septic Shock","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2013-01","conditions":["Septic Shock"],"enrollment":1000,"completionDate":"2016-01"},{"nctId":"NCT02306239","phase":"NA","title":"The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients","status":"UNKNOWN","sponsor":"Liu ZiMeng","startDate":"2014-12","conditions":["Terlipressin","Septic Shock"],"enrollment":40,"completionDate":""},{"nctId":"NCT02311608","phase":"","title":"Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2014-02","conditions":["Liver Cirrhosis","Esophageal and Gastric Varices","Hemorrhage"],"enrollment":1320,"completionDate":"2016-06"},{"nctId":"NCT00742339","phase":"PHASE2,PHASE3","title":"Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome","status":"TERMINATED","sponsor":"University of Padova","startDate":"2005-05","conditions":["Cirrhosis","Hepatorenal Syndrome"],"enrollment":49,"completionDate":"2013-10"},{"nctId":"NCT01271114","phase":"PHASE3","title":"Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension","status":"TERMINATED","sponsor":"Hospital General de Ciudad Real","startDate":"2012-06","conditions":["Septic Shock","Sepsis-associated Hypotension"],"enrollment":21,"completionDate":"2013-12"},{"nctId":"NCT01932151","phase":"NA","title":"Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2012-12","conditions":["Hepatorenal Syndrome"],"enrollment":18,"completionDate":"2013-08"},{"nctId":"NCT01335516","phase":"","title":"Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-11","conditions":["Gastrointestinal Bleeding","Oesophageal Varices"],"enrollment":20,"completionDate":"2011-08"},{"nctId":"NCT01637454","phase":"PHASE3","title":"TYPE 2 HEPATORENAL SYNDROME","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2009-01","conditions":["Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS"],"enrollment":46,"completionDate":"2011-12"},{"nctId":"NCT01373606","phase":"PHASE1,PHASE2","title":"A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2007-11","conditions":["Hepatorenal Syndrome Type 1"],"enrollment":8,"completionDate":"2009-12"},{"nctId":"NCT01112852","phase":"PHASE4","title":"EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal Bleeding","status":"COMPLETED","sponsor":"National Science and Technology Council, Taiwan","startDate":"2006-12","conditions":["Esophageal Varices","Bleeding"],"enrollment":118,"completionDate":"2010-04"},{"nctId":"NCT00863837","phase":"PHASE4","title":"Prevention of Esophageal Variceal Rebleeding","status":"UNKNOWN","sponsor":"National Science and Technology Council, Taiwan","startDate":"2006-12","conditions":["Esophageal Variceal Rebleeding"],"enrollment":120,"completionDate":"2009-12"},{"nctId":"NCT00793559","phase":"PHASE2","title":"Terlipressin Administration in Septic Shock Refractory to Catecholamines","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2008-11","conditions":["Septic Shock"],"enrollment":30,"completionDate":"2009-07"},{"nctId":"NCT00369694","phase":"PHASE4","title":"Short Course Terlipressin for Control of Acute Variceal Bleeding","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2006-08","conditions":["Hemorrhage","Esophageal Varices","Portal Hypertension"],"enrollment":130,"completionDate":"2008-08"},{"nctId":"NCT00370253","phase":"PHASE3","title":"Noradrenalin vs Terlipressin in Hepatorenal Syndrome","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2006-09","conditions":["Hepatorenal Syndrome"],"enrollment":20,"completionDate":"2007-09"},{"nctId":"NCT00481572","phase":"PHASE2","title":"Continuous Infusion of Terlipressin in Septic Shock","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2007-01","conditions":["Septic Shock"],"enrollment":45,"completionDate":"2007-12"},{"nctId":"NCT00534677","phase":"PHASE4","title":"The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2004-05","conditions":["Portal Hypertension","Cirrhosis","Hematemesis","Melena"],"enrollment":320,"completionDate":"2005-07"},{"nctId":"NCT00287664","phase":"PHASE4","title":"Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin","status":"SUSPENDED","sponsor":"Hospital Clinic of Barcelona","startDate":"2002-02","conditions":["Cirrhosis","Hepatorenal Syndrome"],"enrollment":100,"completionDate":"2006-09"},{"nctId":"NCT00115947","phase":"PHASE2,PHASE3","title":"Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2004-12","conditions":["Cirrhosis","Ascites"],"enrollment":0,"completionDate":"2006-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000147058","NDDF":"002124","UNII":"7CZF3L922Y","VUID":"4018755","CHEBI":"CHEBI:6603","VANDF":"4018755","INN_ID":"1481","RXNORM":"6531","UMLSCUI":"C0024328","chemblId":"CHEMBL1200690","ChEMBL_ID":"CHEMBL1200690","KEGG_DRUG":"D00366","DRUGBANK_ID":"DB14642","PUBCHEM_CID":"644076","SNOMEDCT_US":"418230009","MESH_DESCRIPTOR_UI":"D008236"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Novartis","relationship":"Original Developer"}],"publicationCount":24,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"H01BA03","allCodes":["H01BA03"]},"biosimilarFilings":[],"originalDeveloper":"Novartis","recentPublications":[],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"Novartis","companyId":"novartis","modality":"Recombinant protein","firstApprovalDate":"1982","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:09:01.719430+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}